Treatment with U0126 and SP600125 also attenuated the GnRH-II-induced cell migration and invasion, further indicating that the GnRH-II-induced activation of ERK1/2 and JNK may have an important role in the regulation of cell motility in Ishikawa endometrial cancer cells. This evidence concerns the gene MAPK3 and endometrial cancer.